Merck

Healthcare

Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot

Photo via imageBROKER/Rupert Oberh�user/Newscom

A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD.

2 min read

Photo via Image courtesy of Genmab, All rights reserved. © 2024 Genmab A/S

Healthcare

Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus

BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.”

2 min read
Photo by Sundry Photography via iStock

Healthcare

Merck, Pfizer Wade into a New World for Vaccines

Pharma giant Merck on Tuesday announced in its earnings report that it would halt all shipments of HPV drug Gardasil to China.

2 min read
Photo by JHVEPhoto via iStock

Healthcare

Merck Takes on Brain Cancer With Acquisition of Yale Spinoff Modifi

Modifi Biosciences announced that it has been acquired by global pharmaceutical giant Merck, with a $30 million down payment.

1 min read

Healthcare

Pfizer on Opposite Sides of Two Promising Vaccine Trials

Photo by Anastasia Nelen via Unsplash

Data from two promising vaccine trials heralded potential breakthroughs in the treatment of pneumococcal infection and Lyme disease.

1 min read

Photo by Polina Tankilevitch via Pexels

Healthcare

Moderna Inches Nearer to Successful Cancer Vaccine

The company announced positive results in an early-stage trial of the individualized cancer vaccine it developed with Merck.

1 min read
(Photo by Towfiqu Barbhuiya on Unsplash)

Healthcare

Pharma Giants Combine Forces to Fight New M&A Rules

Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.

2 min read
Photo Credit: Adobe.com.

Healthcare

Merck Staring Down Patent Cliff of Its Lucrative Cancer Wonder Drug

1 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.